Pharmaceuticals

Drug Development Drug Safety Weight Loss Drugs Weight Loss Clinical Trials Drug Pricing Drug Regulation Drug Approval Medications Over-the-Counter Medications

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

The move aligns oversight with the realities of small‑batch, personalized products to address serious unmet needs.

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins

Zymeworks and BeOne Say Phase 3 Zanidatamab Regimens Top Two Years’ Survival in First-Line HER2+ GEA

Trump Urges Pregnant Women to Avoid Tylenol as HHS Cuts Childhood Vaccine Schedule

Variant Bio Launches Agentic AI Genomics Platform as It Secures Boehringer Ingelheim Kidney-Disease Deal

Argenx Sets CEO Succession, Tapping COO Karen Massey as Tim Van Hauwermeiren Moves to Chair

Insilico and Servier Strike Up to $888 Million AI-Oncology Partnership

Novo Nordisk Leans on Wegovy’s New MASH Indication and First Oral Obesity Pill to Rebound in 2026

Law Firms Urge Telix Investors as Jan. 9 Lead-Plaintiff Deadline Nears

Hagens Berman and Pomerantz Launch Probes Into Rezolute After Phase 3 Ersodetug Failure

RFK Jr. Overhauls HHS With Deep Cuts, MAHA Push and Vaccine Policy Reversals

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline

Law Firms Urge Telix Investors Ahead of Lead‑Plaintiff Deadline in Securities Class Action

Cell Study Finds ADHD Stimulants Boost Wakefulness and Reward Systems, Not Attention Circuits

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

RMIT Engineers Nanodots That Kill Cancer Cells in Lab Tests While Largely Sparing Healthy Cells

Nvidia Reportedly Pauses Intel 18A Chip Tests, Knocking Intel Shares

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal